fig4
![Efficacy and safety of stereotactic body radiation therapy combined with transarterial chemoembolization for Chinese intermediate-to advanced-stage hepatocellular carcinoma patients: a systematic review and meta-analysis](https://image.oaes.cc/716fef8a-11e0-43be-98cf-1f994711d75a/3084.fig.4.jpg)
Figure 4. Meta-analysis of the one-year survival rate in 13 studies comparing transarterial chemoembolization (TACE) plus stereotactic body radiation therapy (SBRT) with TACE or SBRT monotherapy for intermediate-to advanced-stage hepatocellular carcinoma patients